The United States has withdrawn its support from a significant HIV prevention program in Africa, which had planned to distribute a highly effective new drug across the continent this year. This decision has raised concerns as much of the funding for the initiative is now at risk, potentially undermining efforts to curb the spread of HIV.
A nurse in Mhlosheni, Eswatini, highlights the impact of this setback, noting that from January to, nearly 5,000 individuals with HIV failed to collect their medication due to clinic closures and the dismissal of outreach workers, underscoring the broader implications of the funding withdrawal on public health outcomes.